The Mercedes Vision AVTR brings one of the brand’s most unusual concept cars onto the streets of Hollywood. Its flowing ...
GLP-1 injections have become an increasingly popular form of treatment for obesity in recent years, with millions of people reportedly using the medication. However, there is an uncommon side effect ...
Meta’s $1,299 VR Glasses combine 5K displays, AI, gesture controls and virtual desktops in a lighter headset powered by a separate compute puck. Meta VR Glasses combine high-resolution displays, AI ...
BIRMINGHAM, Ala. (WBRC) - Multiple lawsuits filed within the last year focus on a condition called non-arteritic anterior ischemic optic neuropathy, or NAION, which causes rapid-onset vision changes ...
Meta unveiled its long-anticipated VR Glasses at Connect 2026 on Tuesday, finally delivering the lightweight headset that analysts have been expecting since leaks of "Project Phoenix" began ...
Meta Platforms Inc. on Wednesday launched $1,299 virtual-reality glasses that undercut Apple Inc. in price and size while putting its headset line on track for profitability. The new device, called ...
Two pharmaceutical giants that produce GLP-1 weight-loss drugs are facing lawsuits filed by people who claim their vision loss was caused by the medications. The lawsuits claim Novo Nordisk, the maker ...
Lawsuits claim the new GLP-1 weight-loss drugs are causing rare form of vision loss GLP-1 weight loss drugs are causing NAION. It's essentially nerve damage to your eye, and can lead to permanent ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. “It’s been very challenging,” she says. Here’s what doctors say about the risk. Hundreds of ...
Hundreds of consumers are suing the manufacturers of GLP-1 receptor agonists, alleging the medications may increase the risk of a rare form of vision loss. The patients behind the lawsuits allege that ...